Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$1.48 - $2.88 $53,504 - $104,117
36,152 New
36,152 $54.6 Million
Q4 2022

Feb 14, 2023

BUY
$1.19 - $1.91 $43,020 - $69,050
36,152 New
36,152 $57,000
Q2 2022

Aug 15, 2022

SELL
$1.53 - $2.89 $269,445 - $508,952
-176,108 Reduced 82.96%
36,185 $66,000
Q1 2022

May 11, 2022

SELL
$2.67 - $4.68 $2,114 - $3,706
-792 Reduced 0.37%
212,293 $567,000
Q4 2021

Feb 11, 2022

BUY
$3.87 - $7.39 $11,602 - $22,155
2,998 Added 1.43%
213,085 $923,000
Q3 2021

Nov 12, 2021

BUY
$4.32 - $6.43 $67,353 - $100,250
15,591 Added 8.02%
210,087 $1.07 Million
Q2 2021

Aug 11, 2021

SELL
$6.33 - $9.91 $17,344 - $27,153
-2,740 Reduced 1.39%
194,496 $1.23 Million
Q1 2021

May 13, 2021

BUY
$6.6 - $9.0 $137,445 - $187,425
20,825 Added 11.8%
197,236 $1.52 Million
Q4 2020

Feb 09, 2021

SELL
$6.47 - $7.9 $33,689 - $41,135
-5,207 Reduced 2.87%
176,411 $1.16 Million
Q3 2020

Nov 12, 2020

BUY
$6.55 - $8.83 $3,497 - $4,715
534 Added 0.29%
181,618 $1.21 Million
Q2 2020

Aug 12, 2020

SELL
$7.4 - $14.64 $104,687 - $207,112
-14,147 Reduced 7.25%
181,084 $1.51 Million
Q1 2020

May 06, 2020

BUY
$3.61 - $8.6 $23,768 - $56,622
6,584 Added 3.49%
195,231 $1.5 Million
Q4 2019

Feb 14, 2020

SELL
$5.17 - $8.91 $22,789 - $39,275
-4,408 Reduced 2.28%
188,647 $1.57 Million
Q3 2019

Nov 07, 2019

BUY
$7.38 - $12.25 $83,342 - $138,339
11,293 Added 6.21%
193,055 $1.42 Million
Q2 2019

Aug 12, 2019

SELL
$9.35 - $11.41 $44,356 - $54,129
-4,744 Reduced 2.54%
181,762 $2.04 Million
Q1 2019

May 14, 2019

BUY
$9.5 - $19.16 $9,063 - $18,278
954 Added 0.51%
186,506 $2.01 Million
Q4 2018

Feb 11, 2019

BUY
$12.69 - $18.61 $139,678 - $204,840
11,007 Added 6.31%
185,552 $2.8 Million
Q3 2018

Nov 09, 2018

BUY
$18.04 - $26.41 $348,244 - $509,818
19,304 Added 12.43%
174,545 $0
Q2 2018

Aug 06, 2018

BUY
$21.38 - $29.68 $422,233 - $586,150
19,749 Added 14.58%
155,241 $3.55 Million
Q1 2018

May 15, 2018

BUY
$21.76 - $34.22 $127,404 - $200,358
5,855 Added 4.52%
135,492 $3.85 Million
Q4 2017

Feb 09, 2018

BUY
$19.0 - $23.09 $2.46 Million - $2.99 Million
129,637
129,637 $2.74 Million

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $55.4M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.